Singapore markets open in 7 hours 37 minutes

Sino Biopharmaceutical Limited (1177.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
4.790+0.070 (+1.48%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 82.41B
Enterprise value 78.10B
Trailing P/E 5.10
Forward P/E 11.52
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.68
Price/book (mrq)2.32
Enterprise value/revenue 2.91
Enterprise value/EBITDA 3.93

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 3-39.10%
S&P500 52-week change 3-8.83%
52-week high 37.900
52-week low 33.620
50-day moving average 34.144
200-day moving average 35.219

Share statistics

Avg vol (3-month) 345.51M
Avg vol (10-day) 344.97M
Shares outstanding 518.82B
Implied shares outstanding 6N/A
Float 88.74B
% held by insiders 147.86%
% held by institutions 114.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.16
Forward annual dividend yield 43.70%
Trailing annual dividend rate 30.06
Trailing annual dividend yield 31.38%
5-year average dividend yield 40.72
Payout ratio 44.54%
Dividend date 3N/A
Ex-dividend date 415 Jun 2022
Last split factor 23:2
Last split date 320 Jul 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 54.38%
Operating margin (ttm)15.74%

Management effectiveness

Return on assets (ttm)4.91%
Return on equity (ttm)55.25%

Income statement

Revenue (ttm)26.86B
Revenue per share (ttm)1.43
Quarterly revenue growth (yoy)13.30%
Gross profit (ttm)21.53B
EBITDA 5.05B
Net income avi to common (ttm)14.61B
Diluted EPS (ttm)0.241
Quarterly earnings growth (yoy)232.80%

Balance sheet

Total cash (mrq)15.79B
Total cash per share (mrq)0.85
Total debt (mrq)12.25B
Total debt/equity (mrq)32.48
Current ratio (mrq)1.53
Book value per share (mrq)1.62

Cash flow statement

Operating cash flow (ttm)5.37B
Levered free cash flow (ttm)-449.28M